Approaches to the control of viral infections in man.
D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D002642:Chick Embryo; D003561:Cytarabine / Q000627:therapeutic use; D003857:Deoxyuridine / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007252:Influenza Vaccines / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D009108:Mumps Vaccine / Q000627:therapeutic use; D011054:Poliovirus Vaccine, Inactivated / Q000627:therapeutic use; D011819:Rabies Vaccines / Q000627:therapeutic use; D012411:Rubella Vaccine / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use; D014777:Virus Diseases / Q000517:prevention & control*
D007252:Influenza Vaccines; D009108:Mumps Vaccine; D011054:Poliovirus Vaccine, Inactivated; D011819:Rabies Vaccines; D012411:Rubella Vaccine; D013882:Thiosemicarbazones; D014765:Viral Vaccines; D003561:Cytarabine; D007372:Interferons; D000547:Amantadine; D003857:Deoxyuridine